Gilead Submits New Drug Application to U.S. ...
15:10 EDT 28 Jun 2012 | LaMerie
Elvitegravir Also a Component of Quad Single Tablet Regimen, Currently Under Regulatory Review for Patients New to Therapy
Original Article: Gilead Submits New Drug Application to U.S. ...
More From BioPortfolio on "Gilead Submits New Drug Application to U.S. ..."
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
